Universal Biosensors Inc. | Income Statement

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,089.70
9,529.70
16,775.00
18,830.80
25,191.30
69,456.90
Cost of Goods Sold (COGS) incl. D&A
12,325.10
2,976.30
3,856.20
3,585.80
6,052.00
4,233.40
Gross Income
2,764.60
6,553.40
12,918.80
15,245.10
19,139.30
65,223.60
SG&A Expense
21,002.40
22,473.00
24,715.50
18,968.30
18,123.30
18,800.90
EBIT
18,237.80
15,919.60
11,796.70
3,723.30
1,016.00
46,422.70
Non Operating Income/Expense
6,923.80
930.60
923.50
113.00
727.90
569
Interest Expense
819.80
2,662.00
3,323.20
2,902.70
2,803.30
2,991.10
Pretax Income
11,633.80
19,251.20
15,800.80
6,311.90
887.10
41,916.90
Income Tax
-
9,935.10
9,224.30
7,562.20
122.30
4,352.60
Consolidated Net Income
11,633.80
9,316.10
6,576.40
1,250.30
764.70
37,564.40
Net Income
11,633.80
9,316.10
6,576.40
1,250.30
764.70
37,564.40
Net Income After Extraordinaries
11,633.80
9,316.10
6,576.40
1,250.30
764.70
37,564.40
Net Income Available to Common
11,633.80
9,316.10
6,576.40
1,250.30
764.70
37,564.40
EPS (Basic)
0.07
0.05
0.04
0.01
0.00
0.21
Basic Shares Outstanding
174,428.30
175,608.60
175,881.20
176,189.10
176,417.40
176,732.20
EPS (Diluted)
0.07
0.05
0.04
0.01
0.00
0.21
Diluted Shares Outstanding
174,428.30
175,608.60
175,881.20
177,373.80
176,417.40
177,152.90
EBITDA
15,740.50
13,406.60
9,099.50
1,077.10
3,605.50
48,536.20
Non-Operating Interest Income
500.00
260.90
242.60
201.10
172.40
491

About Universal Biosensors

View Profile
Address
1 Corporate Avenue
Rowville Victoria (VIC) 3178
Australia
Employees -
Website http://www.universalbiosensors.com
Updated 07/08/2019
Universal Biosensors, Inc. engages in the research, development, and manufacture of medical diagnostics test systems for point-of-care professional and home use. Its products includes blood glucose monitoring, coagulation testing, immunoassay, and molecular diagnostics. The company was founded on September 14, 2001 and is headquartered in Rowville, Australia.